The Food and Drug Administration (FDA) and Co-sponsor International Color Consortium (ICC) are announcing a public workshop entitled ?Summit on Color in Medical Imaging: An International workshop on the Technical Framework for Consistency and...
NORTHWOOD, Ohio--(BUSINESS WIRE)--Mar 26, 2013--NAMSA, the world’s leading medical research organization, continues its steady growth with the expansion of its microbiology laboratory in Irvine, California. The newly expanded and state-of-the-art laboratory space will utilize the latest technology...
InSite Vision eked out a narrow win against the University of California in San Francisco in a patent battle over eye treatment. Alameda, Calif.-based InSite touted a split U.S. Court Federal Circuit Court of Appeals decision in its favor, upholding the U.S. Patent & Trademark Office's panel ruling.
Harbor MedTech Announces Market Launch of Architect™, an Advanced Collagen Matrix for Treating Serious Skin WoundsMarch 26, 2013 2:00 pm | by The Associated Press | News | Comments
IRVINE, Calif.--(BUSINESS WIRE)--Mar 26, 2013--Harbor MedTech, Inc. announced today notification of FDA marketing clearance for their first product, Architect™, an advanced collagen matrix for treatment of partial and full thickness skin wounds. “We are very excited that the FDA has cleared...
Federal health officials issued a rare warning Tuesday about doctors' ownership of shares in medical device companies that allow them to profit from performing surgeries with those products. The Depart of Health and Human Services' inspector general said the increasingly common practice is "inherently suspect" and may violate anti-kickback laws, according to the special fraud alert.
Israel and Minnesota-based BioControl Medical won FDA approval to proceed with the 3rd and largest phase of its INOVATE-HF trail, evaluating its CardioFit vagal nerve stimulation system in treatment of heart failure. The global, multi-center trial aims to provide clinical data in support of BioControl's premarket approval application for FDA clearance of the CardioFit system.
PET scan, CT, and MRI are almost standard in today’s diagnostics – highly developed and very sophisticated. Although more capable and less cost-intensive, laser-optical diagnosis methods are, up to now, far less prevalent. FAMOS is aiming to change this.
In an engineering breakthrough, a Washington University in St. Louis biomedical researcher has discovered a way to use light and color to measure oxygen in individual red blood cells in real time.
Tubes with an outer diameter as small as 0.15 mm are available from Goodfellow in lengths ranging from a fraction of a meter to large production runs. The 0.15 mm OD tube is 99.95% gold and has an inner diameter of 0.05 mm.
Robotic Positioning Arm Allows Proton Beams to Pinpoint Difficult-to-Reach Tumors at Loma Linda University Medical CenterMarch 26, 2013 11:00 am | by The Associated Press | News | Comments
LOMA LINDA, Calif.--(BUSINESS WIRE)--Mar 26, 2013--For more than three decades various forms of robotics have been effectively applied in healthcare to advance different types of medical treatment and surgical processes. Now, the nation’s first robotic positioning arm for proton therapy is being...
Computype, Inc., in partnership with Nautilus Systems, today announced the launch of the Flexible Tube and Vial Feeder (Flex TVF), an innovative new system for automatic downstream feeding of tubes and vials that helps increase efficiency.
The Model 455 dispensing valve from Dymax Corporation is a pneumatically operated, normally closed pinch valve with a disposable fluid path. It was designed to dispense a variety of low- to medium-viscosity materials with extreme precision.
Bimba Manufacturing, an industry-leading provider of pneumatic, hydraulic, and electric motion control solutions, announced today the release of the Original Line Electric Thruster (OLET), the newest addition to the electric motion control line.
White blood cells, or leukocytes, are the immune system's warriors. So when an infection or disease attacks the body, the system typically responds by sending more white blood cells into the fray. This means that checking the number of these cells is a relatively easy way to detect and monitor such conditions.
Johnson & Johnson has announced a voluntary recall for all its OneTouch VerioIQ blood glucose meters in the U.S. because they do not provide a warning when a diabetic's blood sugar level is dangerously high. Instead, the meters turn off.